Close - PCSK9 inhibitors: the next chapter in CVD prevention.

26 August 2017 (00:00 - 00:00)

Organised by:

About the speaker

Professor John Chapman

Pitie Salpetriere APHP University Hospital, Paris (France)

4 More presentations in this session

Presentation thumbnail

Introduction - PCSK9 inhibitors: the next chapter in CVD prevention.

Presentation thumbnail

CVD prevention and event reduction.

Professor M. Sabatine (Boston, US)

Presentation thumbnail

Future perspectives in lipid lowering and CVD prevention.

Professor P. Sever (London, GB)

Presentation thumbnail

Panel discussion - PCSK9 inhibitors: the next chapter in CVD prevention.

Professor J. Chapman (Paris, FR)

Access the full session

Session thumbnail

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in cardiovascular disease prevention

The Event

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources